DK446684A - Farmaceutisk middel indeholdende et renset, afgiftet endotoksin i kombination med en pyridinoploeselig ekstrakt af en mikroorganisme - Google Patents

Farmaceutisk middel indeholdende et renset, afgiftet endotoksin i kombination med en pyridinoploeselig ekstrakt af en mikroorganisme Download PDF

Info

Publication number
DK446684A
DK446684A DK446684A DK446684A DK446684A DK 446684 A DK446684 A DK 446684A DK 446684 A DK446684 A DK 446684A DK 446684 A DK446684 A DK 446684A DK 446684 A DK446684 A DK 446684A
Authority
DK
Denmark
Prior art keywords
endotoxine
taxed
organism
pyridine
purified
Prior art date
Application number
DK446684A
Other languages
Danish (da)
English (en)
Other versions
DK446684D0 (da
Inventor
John Leonard Cantrell
Original Assignee
Ribi Immunochem Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ribi Immunochem Research Inc filed Critical Ribi Immunochem Research Inc
Publication of DK446684D0 publication Critical patent/DK446684D0/da
Publication of DK446684A publication Critical patent/DK446684A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • A61K2039/585—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
DK446684A 1983-09-23 1984-09-19 Farmaceutisk middel indeholdende et renset, afgiftet endotoksin i kombination med en pyridinoploeselig ekstrakt af en mikroorganisme DK446684A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/535,037 US4663306A (en) 1983-09-23 1983-09-23 Pyridine-soluble extract-refined detoxified endotoxin composition and use

Publications (2)

Publication Number Publication Date
DK446684D0 DK446684D0 (da) 1984-09-19
DK446684A true DK446684A (da) 1985-03-24

Family

ID=24132594

Family Applications (1)

Application Number Title Priority Date Filing Date
DK446684A DK446684A (da) 1983-09-23 1984-09-19 Farmaceutisk middel indeholdende et renset, afgiftet endotoksin i kombination med en pyridinoploeselig ekstrakt af en mikroorganisme

Country Status (23)

Country Link
US (1) US4663306A (enExample)
JP (1) JPS60120817A (enExample)
KR (1) KR870000843B1 (enExample)
AT (1) AT385659B (enExample)
AU (1) AU566234B2 (enExample)
BE (1) BE900650A (enExample)
CA (1) CA1244765A (enExample)
CH (1) CH664897A5 (enExample)
DE (1) DE3434766C2 (enExample)
DK (1) DK446684A (enExample)
ES (1) ES8608872A1 (enExample)
FI (1) FI843716L (enExample)
FR (1) FR2552326B1 (enExample)
GB (1) GB2149301B (enExample)
HU (1) HU192585B (enExample)
IL (1) IL73034A (enExample)
IN (1) IN157240B (enExample)
IT (1) IT1179444B (enExample)
NL (1) NL8402902A (enExample)
NO (1) NO843776L (enExample)
NZ (1) NZ209635A (enExample)
SE (1) SE8404707L (enExample)
ZA (1) ZA847405B (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4844894A (en) * 1984-07-12 1989-07-04 Ribi Immunochem Research Inc. Method of inhibiting the onset of septicemia and endotoxemia
US4806352A (en) * 1986-04-15 1989-02-21 Ribi Immunochem Research Inc. Immunological lipid emulsion adjuvant
US4877611A (en) * 1986-04-15 1989-10-31 Ribi Immunochem Research Inc. Vaccine containing tumor antigens and adjuvants
US4929604A (en) * 1986-05-28 1990-05-29 Board Of Regents, The University Of Texas System Lipopolysaccharides of reduced toxicity and the production thereof
WO1995005837A1 (en) * 1993-08-27 1995-03-02 Vetrepharm, Inc. Composition and method for stimulation of reproductive performance
US6090385A (en) * 1993-12-10 2000-07-18 Maes; Hubert Method of treating cancer
BE1007823A3 (fr) * 1993-12-10 1995-10-31 Anda Biolog Sa Utilisation d'une composition comprenant au moins un antigene et/ou un ou plusieurs fragments de cet antigene pour l'obtention d'un medicament destine au traitement et/ou a la prevention du cancer.
US5976580A (en) 1995-06-07 1999-11-02 Novus International, Inc. Nutrient formulation and process for enhancing the health, livability, cumulative weight gain or feed efficiency in poultry and other animals
DE19710255A1 (de) * 1997-03-13 1998-09-17 Henkel Ecolab Gmbh & Co Ohg Verwendung einer Lösung zur Desaktivierung von Endotoxinen
HU227921B1 (hu) 1997-08-05 2012-06-28 Bioniche Life Sciences Inc Készítmény és eljárás sejtproliferáció és sejtpusztulás szabályozására
US6019985A (en) * 1998-02-27 2000-02-01 Munova Corporation Immunostimulation methods for providing disease protection in poultry
KR100628007B1 (ko) 1998-07-16 2006-09-26 이치로 아즈마 세균의 균체성분을 유효성분으로 하는 암면역요법용 제제
AU785212B2 (en) * 1999-12-13 2006-11-09 Bioniche Life Sciences Inc. Therapeutically useful synthetic oligonucleotides
DK1250152T3 (da) * 1999-12-28 2013-08-26 Bioniche Urology Ip Inc Synergistisk sammensætning indeholdende hyaluronsyre til behandling af cancer
JP5106736B2 (ja) * 2000-07-11 2012-12-26 アイキュリス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング・ウント・コムパニー・コマンディットゲゼルシャフト 臓器線維形成に対するパラポックスウイルスｏｖｉｓ株の使用
JP4176021B2 (ja) * 2002-03-05 2008-11-05 セルメディシン株式会社 固体化組織免疫アジュバント
WO2004012751A1 (ja) * 2002-08-02 2004-02-12 Sumitomo Pharmaceuticals Company, Limited 細菌細胞壁骨格成分製剤
FR2848223B1 (fr) * 2002-12-09 2005-02-25 Centre Nat Rech Scient Nouveau procede d'isolement des endotoxines.
AU2003261624A1 (en) * 2003-09-05 2005-03-29 Shenyang Sunbellcom Bio-Pharmaceutical Co., Ltd. A red nocardia cell wall skeleton preparation process and its therapeutic use on treating cervical erosion
WO2005102369A1 (ja) * 2004-04-22 2005-11-03 Dainippon Sumitomo Pharma Co., Ltd. 細菌細胞壁骨格成分を含有する製剤
HK1214510A1 (zh) 2013-04-18 2016-07-29 Immune Design Corp. 用於癌症治疗的gla单一疗法
US9463198B2 (en) 2013-06-04 2016-10-11 Infectious Disease Research Institute Compositions and methods for reducing or preventing metastasis
PL3158054T3 (pl) 2014-06-17 2025-07-21 Crown Laboratories, Inc. Bakterie zmodyfikowane genetycznie i sposoby modyfikacji genetycznej bakterii
US11504404B2 (en) 2016-02-24 2022-11-22 Crown Laboratories, Inc. Skin probiotic formulation
EP3668957A4 (en) * 2017-08-17 2021-06-02 University of Delaware Furan based compositions and methods of making thereof
JP2023533202A (ja) 2020-06-23 2023-08-02 クラウン ラボラトリーズ，インコーポレイテッド プロバイオティクス皮膚製剤

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7308450A (enExample) * 1972-06-20 1973-12-27
FR2269962B1 (enExample) * 1974-05-06 1978-02-03 Anvar
JPS58874B2 (ja) * 1979-08-30 1983-01-08 株式会社 目黒研究所 糖蛋白ｗｅｎａｃ及びその製造法
US4436727A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4436728A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4435386A (en) * 1982-05-26 1984-03-06 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
CA1206416A (en) * 1982-06-30 1986-06-24 John L. Cantrell Pyridine soluble extract of a microorganism
CA1209504A (en) * 1982-06-30 1986-08-12 John L. Cantrell Pyridine soluble extract of a microorganism
CA1206415A (en) * 1982-06-30 1986-06-24 John L. Cantrell Pyridine soluble extract of a microorganism

Also Published As

Publication number Publication date
FR2552326B1 (fr) 1988-05-13
IL73034A (en) 1988-11-15
DK446684D0 (da) 1984-09-19
DE3434766C2 (de) 1987-05-14
KR850002404A (ko) 1985-05-13
NZ209635A (en) 1989-01-27
SE8404707D0 (sv) 1984-09-20
CH664897A5 (de) 1988-04-15
GB2149301B (en) 1988-06-22
CA1244765A (en) 1988-11-15
AU3340084A (en) 1985-03-28
NO843776L (no) 1985-03-25
SE8404707L (sv) 1985-03-24
FR2552326A1 (fr) 1985-03-29
ZA847405B (en) 1985-05-29
FI843716A0 (fi) 1984-09-21
JPS60120817A (ja) 1985-06-28
ATA302384A (de) 1987-10-15
DE3434766A1 (de) 1986-04-30
HUT35521A (en) 1985-07-29
NL8402902A (nl) 1985-04-16
GB8423993D0 (en) 1984-10-31
GB2149301A (en) 1985-06-12
IT8448894A0 (it) 1984-09-24
IN157240B (enExample) 1986-02-15
KR870000843B1 (ko) 1987-04-25
JPS6254775B2 (enExample) 1987-11-17
ES536167A0 (es) 1986-07-16
BE900650A (fr) 1985-03-21
AU566234B2 (en) 1987-10-15
FI843716A7 (fi) 1985-03-24
HU192585B (en) 1987-06-29
AT385659B (de) 1988-05-10
ES8608872A1 (es) 1986-07-16
US4663306A (en) 1987-05-05
IT1179444B (it) 1987-09-16
FI843716L (fi) 1985-03-24

Similar Documents

Publication Publication Date Title
DK446684A (da) Farmaceutisk middel indeholdende et renset, afgiftet endotoksin i kombination med en pyridinoploeselig ekstrakt af en mikroorganisme
NO166518C (no) Stol med vektsavhengig tilbakestillingskraft for rygglenet
ES553764A0 (es) Un procedimiento para fabricar un articulo de una composicion fotopolimerizable.
DK569784D0 (da) Farmaceutisk baeremedium med forsinket virkning
FI861122L (fi) Digitaalinen skaalauspiiri katkaisupoikkeaman kompensoimiseksi
SE8801813D0 (sv) Pharmaceutical composition
IT1209667B (it) Composizione effeverscente adattivita' analgesica.
DK408788D0 (da) Fremstilling af terapeutiske ringe
FI821240A0 (fi) Med dubbelmod fungerande maetaravlaesningsanordning
DK529885A (da) Farmaceutiske kapsler med langvarig frigivelse
PH21029A (en) Benzene derivatives, pharmaceutical compositions and method of use thereof
DK49488D0 (da) Anaestesi-praeparat
FI822670L (fi) Ergopeptinderivat, foerfaranden foer deras framstaellning, dessa innehaollande farmaceutiska kompositioner och deras anvaendning vid terapeutisk behandling
FI902673A7 (fi) Anti-inflammatoorisia ja analgeettisia yhdisteitä, niitä sisältäviä se oksia ja menetelmiä niiden valmistamiseksi sekä niiden käyttö
IT1182061B (it) Derivati di amminofenolo, procedimento per prepararli e composizione farmaceutica che li contiene
DK200586D0 (da) Anvendelse af pyridinonforbindelser med antithrombotisk virkning i laegemidler
IT1209615B (it) Composizione farmaceutica
FI852699A7 (fi) Trisykliset dihydropyridatsinonit ja niitä sisältävät farmaseuttiset koostumukset.
DK369385D0 (da) Middel til behandling af schizofreni
BR8602887A (pt) Composicao refrataria
FI853228L (fi) Nya -butyrolaktamer, deras farmaceutiskt aktiva kompositioner, foerfaranden foer deras framstaellning och deras anvaendning som laekemedel.
IL79120A0 (en) Glycerol derivatives,their manufacture and pharmaceutical compositions containing them
IL80448A (en) Purified tnf composition
DK620989D0 (da) Anvendelse af et prostaglandin af e-typen i kombination med cyclosporin til fremstilling af et farmaceutisk praeparat
KR860005809A (ko) 3--1h-인다졸, 이의 제조방법 및 이들 화합물을 함유하는 약제학적 조성물

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment